Galectin Therapeutics Inc — Balance Sheet (NASDAQ:GALT) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 29.6 M41.83 M21.29 M28.2 M17.5 M Total liabilities 5.41 M39.21 M53.48 M88.44 M120.56 M Total equity 22.47 M893 K33.92 M61.96 M104.79 M Total liabilities & shareholders' equities 29.6 M41.83 M21.29 M28.2 M17.5 M Total debt ————— Net debt —————

뉴스

갈락틴 테라퓨틱스 이사, 마크 루빈 사임

Galectin Therapeutics director Marc Rubin resigns from board

Galectin Therapeutics CFO, 23.3만 달러 상당 주식 매도

Galectin Therapeutics CFO sells $233k in shares

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

oracle, micron tech among market cap stock movers on friday

Galectin Therapeutics, FDA 피드백 후 주가 폭락

Galectin Therapeutics stock plummets after FDA feedback on drug

FDA provides feedback on Galectin’s belapectin development program

갈렉틴 테라퓨틱스 이사, 105만 달러 상당 주식 매도

갈렉틴 테라퓨틱스, 이사진 선임 및 주요 제안 승인

Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data (NASDAQ:GALT)